Every day, we sift through the filings to spot where the real conviction lies β cutting through the noise to highlight the most meaningful insider moves.
π Zenas Biopharma $ZBIO β CEO purchased $1.02 Million via Form 4.
Direct buy from the top in a biotech name, signaling confidence as the stock levels out after a gap down.
π DXC Technology $DXC β President and CEO bought $250,706 per Form 4.
Insider accumulation in an IT services name still hovering near its COVID-era lows, where long-term support is being tested.
Hereβs The Hot Corner, with data from February 3, 2026:
π Worthington Steel $WS β Director Jon Bowsher purchased $100,375 via Form 4.
Smaller in size, but contextually interesting as the stock tightens up and works through a year-long basing process.
